US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 3.1000
- +0.1816+6.22%
Close Apr 26 16:00 ET
3.63MMarket Cap-239P/E (TTM)
3.2824High3.0700Low5.25KVolume3.1475Open2.9184Pre Close16.64KTurnover0.46%Turnover RatioLossP/E (Static)1.17MShares11.774052wk High1.88P/B3.54MFloat Cap2.402052wk Low--Dividend TTM1.14MShs Float360.0000Historical High--Div YieldTTM7.28%Amplitude2.4020Historical Low3.1710Avg Price1Lot Size
Virpax Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.79%-9.85M | -92.14%-3.01M | 51.79%-2.65M | 53.91%-2.18M | 66.78%-2.01M | -22.72%-17.85M | 68.16%-1.57M | -15.94%-5.5M | -163.48%-4.74M | -96.25%-6.04M |
| Net income from continuing operations | 29.84%-15.19M | -52.71%-4.56M | 21.56%-5.99M | 47.10%-3.11M | 70.40%-1.52M | -79.58%-21.65M | 27.46%-2.99M | -137.64%-7.64M | -151.12%-5.88M | -115.91%-5.14M |
| Change In working capital | 56.62%4.79M | 21.72%1.56M | 57.98%3.15M | -21.29%711.59K | 43.85%-628.42K | 190.00%3.06M | 235.49%1.28M | 229.23%1.99M | 374.72%904.01K | -1.60%-1.12M |
| -Change in prepaid assets | -90.67%191.53K | -83.36%398.56K | -2.31%261.97K | -40.90%359.06K | 32.04%-828.07K | 175.66%2.05M | 239.84%2.39M | 376.35%268.16K | 1,679.79%607.53K | -30.06%-1.22M |
| -Change in payables and accrued expense | 160.36%599.43K | 105.18%161.3K | -106.61%-114.05K | 18.90%352.53K | 101.26%199.65K | -44.60%-993.1K | -506.09%-3.11M | 219.35%1.72M | 89.69%296.48K | 160.21%99.2K |
| -Change in other current liabilities | 100.00%4M | -50.00%1M | ---- | ---- | ---- | --2M | --2M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.79%-9.85M | -92.14%-3.01M | 51.79%-2.65M | 53.91%-2.18M | 66.78%-2.01M | -22.72%-17.85M | 68.16%-1.57M | -15.94%-5.5M | -163.48%-4.74M | -96.25%-6.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -48.44%19M | -40.90%12.15M | -43.20%14.8M | -44.84%16.99M | -48.44%19M | 67,134.82%36.84M | -50.71%20.56M | 148.99%26.06M | 151.11%30.8M | 67,134.82%36.84M |
| Current changes in cash | 44.79%-9.85M | -92.14%-3.01M | 51.79%-2.65M | 53.91%-2.18M | 66.78%-2.01M | -148.51%-17.85M | 67.83%-1.57M | -117.60%-5.5M | -163.48%-4.74M | -149.51%-6.04M |
| End cash Position | -51.87%9.14M | -51.87%9.14M | -40.90%12.15M | -43.20%14.8M | -44.84%16.99M | -48.44%19M | -48.44%19M | -50.71%20.56M | 148.99%26.06M | 151.11%30.8M |
| Free cash flow | 44.79%-9.85M | -92.14%-3.01M | 51.79%-2.65M | 53.91%-2.18M | 66.78%-2.01M | -22.72%-17.85M | 68.16%-1.57M | -15.94%-5.5M | -163.48%-4.74M | -96.25%-6.04M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg